|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.08 USD | -2.25% |
|
-10.65% | +33.77% |
| 06-12 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
| 06-12 | BeOne Medicines Ltd Showcases Breakthrough Data in CLL and MCL at EHA 2025 | CI |
| Capitalization | 29.99B 26.04B 24.52B 22.31B 41.19B 2,596B 46.5B 289B 111B 1,189B 113B 110B 4,381B | P/E ratio 2025 * |
158x | P/E ratio 2026 * | 37.3x |
|---|---|---|---|---|---|
| Enterprise value | 28.2B 24.48B 23.06B 20.97B 38.73B 2,441B 43.72B 272B 104B 1,118B 106B 104B 4,119B | EV / Sales 2025 * |
5.52x | EV / Sales 2026 * | 4.44x |
| Free-Float |
96.17% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BeOne Medicines Ltd.
More recommendations
More press releases
More news
| 1 day | -2.25% | ||
| 1 week | -10.65% | ||
| Current month | +0.61% | ||
| 1 month | +5.87% | ||
| 3 months | -7.20% | ||
| 6 months | +41.41% | ||
| Current year | +33.77% |
| 1 week | 243.35 |  | 267.53 |
| 1 month | 234.8 | | 284.51 |
| Current year | 172.67 | | 287.88 |
| 1 year | 141.31 | | 287.88 |
| 3 years | 124.46 | | 287.88 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 22.51 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 56 | 28/10/2010 |
Xiao Bin Wu
PSD | President | 63 | 01/04/2018 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 49 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 56 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 50 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 51 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.25% | -10.65% | +59.72% | +86.98% | 29.99B | ||
| +0.39% | -3.98% | +18.34% | +12.67% | 48.12B | ||
| -40.00% | +136.59% | +35,225.28% | +3,297.09% | 31.33B | ||
| +0.08% | -2.77% | -27.30% | -21.44% | 26.75B | ||
| +1.25% | -1.04% | -3.42% | +20.40% | 25.65B | ||
| +0.10% | -1.52% | +13.51% | -19.20% | 12.25B | ||
| -1.14% | -4.10% | +125.22% | - | 11.96B | ||
| +2.02% | -0.41% | -54.03% | -27.08% | 11.41B | ||
| +3.63% | +3.50% | +43.60% | +110.80% | 10.31B | ||
| +0.45% | -1.33% | +3.91% | +0.93% | 10.08B | ||
| Average | -0.27% | +26.90% | +3,540.48% | +384.57% | 21.78B | |
| Weighted average by Cap. | -0.94% | +39.00% | +5,081.05% | +520.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.1B 4.43B 4.17B 3.8B 7.01B 442B 7.91B 49.26B 18.89B 202B 19.15B 18.74B 746B | 6.18B 5.36B 5.05B 4.59B 8.48B 535B 9.57B 59.59B 22.85B 245B 23.17B 22.68B 902B |
| Net income | 131M 113M 107M 97.19M 179M 11.31B 203M 1.26B 484M 5.18B 490M 480M 19.09B | 609M 529M 498M 453M 837M 52.74B 945M 5.88B 2.25B 24.16B 2.29B 2.24B 89B |
| Net Debt | -1.79B -1.56B -1.47B -1.33B -2.46B -155B -2.78B -17.31B -6.64B -71.11B -6.73B -6.59B -262B | -2.55B -2.21B -2.08B -1.89B -3.5B -220B -3.95B -24.57B -9.42B -101B -9.55B -9.35B -372B |
More financial data
* Estimated data
Employees
11,000
Calendar
06-26
- R&D Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/06/25 | 247.08 $ | -2.25% | 230,772 |
| 18/06/25 | 252.78 $ | -0.52% | 230,443 |
| 17/06/25 | 254.09 $ | -3.91% | 424,802 |
| 16/06/25 | 264.42 $ | -1.93% | 326,675 |
| 13/06/25 | 269.63 $ | -2.50% | 391,803 |
Delayed Quote Nasdaq, June 21, 2025 at 12:00 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
247.08USD
Average target price
331.97USD
Spread / Average Target
+34.36%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition